Senti Biosciences Holdings, Inc. [SNTI] - Convertible Note Issuance
Senti Biosciences Holdings, Inc. has issued convertible notes, with details regarding the amount and terms not disclosed in the filing excerpt.
Why this matters
Senti Biosciences Holdings, Inc., based in Delaware, operates in the biological products industry, focusing on developing innovative therapies using synthetic biology. The company has announced the issuance of convertible notes as part of a Securities Purchase Agreement involving Senti Holdings, Senti Biosciences, Inc., and Celadon. This financial move includes a potential merger with an entity affiliated with Celadon, where Senti Holdings would issue a contingent value right to its stockholders, potentially paying up to $60 million in cash contingent on achieving certain milestones related to its product candidate, SENTI-202.